Page 2 - Drugmaker

Moderna to come up with combined Covid and flu booster by 2023

US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at the earliest, CEO Stephane Bancel has said.

Lupin recalls 4,113 cartons of oral contraceptive medicine in US market

Homegrown drug maker Lupin is recalling 4,113 cartons of generic oral contraceptive tablets in the US, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Lupin's US-based unit is recalling 4,113 cartons of Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg). The affected lot has been produced at the company's Pithampur-based manufacturing facility in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals, Inc. The company is recalling the lot due to it being Subpotent Drug, the US health regulator noted in the report. Lupin initiated the nationwide recall on November 19 this year, it added. The USFDA has classified both the recalls as class III. As per the US health regulator, a class III recall is initiated in a situation in which use of, or exposure to, a .

Aurobindo Pharma, Unichem Laboratories recall products in US market

Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets. The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by Princeton-based Aurobindo Pharma USA Inc. The company is recalling the lot due to "failed impurities/degradation specifications", the US health regulator noted in the report. Aurobindo initiated the nationwide the recall on November 15 this year, it added. Another domestic drug maker Unichem Laboratories is recalling 1,284 bottles of Topiramate tablets, used to treat epilepsy (seizures) and to prevent migraines. It is also used in the treatment of Lennox-Gastaut syndrome (a rare, but severe form of epilepsy that starts

Sanofi India net profit at Rs 530 crore in September quarter

The company's revenue from operations rose to Rs 754.5 crore as compared to Rs 686.6 crore in the year-ago period

SoftBank said to build a $5 billion stake in Swiss drugmaker Roche

The Japanese conglomerate is now one of Roche's largest investors, according to data compiled by Bloomberg.

Pharma majors join hands for Molnupiravir trial for Covid-19 treatment

Leading drug makers have decided to collaborate for clinical trial of the investigational oral antiviral drug Molnupiravir

Five drugmakers to jointly start local trial of Merck & Co's Covid-19 drug

(Reuters) -Five Indian generic drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial in India for Merck & Co's experimental anti-viral drug to treat mild COVID-19 in non-hospitalised patients.

Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore

The rise came on account of higher sales.

GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3

GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December

US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end

Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.

Drugmakers to hike prices for 2021 as Covid pressure puts revenues at risk

Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise US prices on more than 300 drugs in the United States on Jan 1

AstraZeneca, Qure.ai to bring AI solutions to detect lung cancer

The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in the markets involved, to reduce mortality rates and improve patient outcomes.

Drugmaker Merck divests stake in vaccine-maker Moderna after stock surge

(Reuters) - U.S. drugmaker Merck & Co said on Wednesday it has sold its equity investment in Moderna Inc, after benefiting from a surge in the stock price of the vaccine developer this year.

PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma

The incentive will be in the range of 5-10 per cent of production value, sources said.

Novartis lifts 2020 forecast as drugmakers see hospitals coping with Covid

ZURICH (Reuters) - Novartis joined rivals Merck, Johnson & Johnson and Roche in predicting the worst of the pandemic may be over for drugmakers, amid signs healthcare systems have learned how to cope with surging infections without shutting down all services.

Covid-19 vaccine makers must deliver to US in time to get full payments

The Cambridge, Massachusetts, biotech's $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021

Moderna shares soar over 16% over coronavirus vaccine trial result

All the 45 patients in the trial produced neutralising antibodies which are believed to be important for building immunity

Drugmakers slash prices to be eligible for China's bulk-buy program

Sale prices of over 100 types of commonly used drugs are on average about 17 to 18 times of their manufacturing costs, the statement said

Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs

More price increases are expected to be announced later this week, which could affect the median and range.

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate